– USA, MN – Solventum (NYSE: SOLV) announced the appointment of Shirley Edwards to its Board of Directors, effective April 12, 2024.
Shirley Edwards will join the Audit and Talent committees.
About Shirley Edwards
From 2002 to 2022, Shirley Edwards distinguished herself as a partner at EY, culminating in her role as a global client service partner from 2017 to 2022. Her career at EY was marked by significant leadership and client service roles, including the stewardship of EY’s nearly $4B assurance practice across 20 countries in the Americas, encompassing 10 regions and a team of over 20,000 professionals. She was instrumental in driving the strategy for audit, forensics, and financial accounting and advisory services throughout the Americas. Beyond her professional achievements, Edwards has contributed her expertise as a board member and advisor to several esteemed organizations, including the Girl Scouts of the Nation’s Capital, Leadership Greater Washington, the Pamplin College of Business Advisory Council at Virginia Tech, National Capital Region Advisory Board for the American Red Cross and is currently a board member at Appian Corporation and Cumming Group.
Shirley Edwards holds a Bachelor of Science in accounting from Virginia Tech.
About Solventum
At Solventum, we enable better, smarter, safer healthcare to improve lives. As a new company with a long legacy of creating breakthrough solutions for our customer’s toughest challenges, we pioneer game-changing innovations at the intersection of health, material, and data science that change patients’ lives for the better — while empowering healthcare professionals to perform at their best.
SOURCE: https://www.solventum.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.